*Optimal dilutions/concentrations should be determined by the researcher.
Not tested in other applications.
H1299 , HeLaS3 , HepG2 , Molt-4 , Raji
Mouse, Dog(>80% identity)
1XPBS, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of human DLC1. The exact sequence is proprietary.
Purified by antigen-affinity chromatography.
For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
ARHGAP7 antibody, FLJ21120 antibody, HP antibody, STARD12 antibody, p122-RhoGAP antibody, DLC1 antibody, StAR-related lipid transfer (START) domain containing 12 antibody, rho-type GTPase-activating protein 7 antibody, deleted in liver cancer 1 variant 2 antibody, deleted in liver cancer 1 protein antibody, Rho-GTPase-activating protein 7 antibody, START domain-containing protein 12 antibody, rho GTPase-activating protein 7 antibody, deleted in liver cancer 1 antibody
This gene is deleted in the primary tumor of hepatocellular carcinoma. It maps to 8p22-p21.3, a region frequently deleted in solid tumors. It is suggested that this gene is a candidate tumor suppressor gene for human liver cancer, as well as for prostate, lung, colorectal, and breast cancers. Alternative splicing at this locus results in several transcript variants encoding different isoforms. [provided by RefSeq]
GTX106392 WB Image
Sample(30 μg of whole cell lysate)
7.5% SDS PAGE
GTX106392 diluted at 1:1500
GTX106392 IHC-P Image
Immunohistochemical analysis of paraffin-embedded Pheochromocytoma xenograft, using DLC1(GTX106392) antibody at 1:100 dilution.
Antigen Retrieval: Trilogy™ (EDTA based, pH 8.0) buffer, 15min